Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 20;12(1):14.
doi: 10.1186/s40035-023-00346-0.

Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy

Affiliations

Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy

Hash Brown Taha et al. Transl Neurodegener. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Biomarker analysis in HC, PD, and MSA. a, b pS129-α-Syn and Tau concentrations were measured using ECLIA, log-transformed, and analyzed by a mixed-effect analysis with post-hoc Tukey test. Data are represented as mean ± SD. Values below the lower limit of detection were imputed as the minimum value divided by 2. c NfL concentrations were measured using Simoa, log-transformed, and analyzed by a one-way ANOVA with post-hoc Tukey test. Data are represented as mean ± SD. d, e ROC analyses of biomarker concentrations using a multinomial logistic regression model with LASSO variable selection (Additional file 1: Fig. S3). The model included nEV α-syn concentration, oEV:nEV α-syn concentration ratio, total EV concentration in the sample and d oEV pS129-α-syn or e oEV tau concentration. The presented models do not include NfL

References

    1. Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, et al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology. 2014;83(5):406–412. doi: 10.1212/WNL.0000000000000641. - DOI - PMC - PubMed
    1. Dutta S, Hornung S, Kruayatidee A, Maina KN, Del Rosario I, Paul KC, et al. α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy. Acta Neuropathol. 2021;142(3):495–511. doi: 10.1007/s00401-021-02324-0. - DOI - PMC - PubMed
    1. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol. 2002;4(2):160–164. doi: 10.1038/ncb748. - DOI - PubMed
    1. Peng C, Gathagan RJ, Covell DJ, Medellin C, Stieber A, Robinson JL, et al. Cellular milieu imparts distinct pathological alpha-synuclein strains in alpha-synucleinopathies. Nature. 2018;557(7706):558–563. doi: 10.1038/s41586-018-0104-4. - DOI - PMC - PubMed
    1. Pan L, Meng L, He M, Zhang Z. Tau in the pathophysiology of Parkinson's disease. J Mol Neurosci. 2021;71(11):2179–2191. doi: 10.1007/s12031-020-01776-5. - DOI - PMC - PubMed

Publication types